# Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

> **NCT05085275** · PHASE3 · COMPLETED · sponsor: **USRC Kidney Research** · enrollment: 289 (actual)

## Conditions studied

- Anemia, Iron Deficiency
- Hyperphosphatemia
- Renal Insufficiency, Chronic
- Renal Anemia
- Disease Progression
- Cardiovascular
- Iron

## Interventions

- **DRUG:** Ferric Citrate 1 GM Oral Tablet [AURYXIA]
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05085275
- **Lead sponsor:** USRC Kidney Research
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-30
- **Primary completion:** 2024-01-24
- **Final completion:** 2024-01-24
- **Target enrollment:** 289 (ACTUAL)
- **Last updated:** 2025-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05085275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05085275, "Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05085275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*